Deflazacort

Product NDC
0054-0825
Requested package NDC
0054-0825-13
11-digit product format
000540825
Labeler code
0054
Product ID
0054-0825_b019324e-dbd3-4404-a0b5-021d67c0270b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Deflazacort
Dosage form
TABLET
Route
ORAL
Labeler
Hikma Pharmaceuticals USA Inc.
Application
ANDA220524
Marketing category
ANDA
Marketing start
2026-10-07
Substance
DEFLAZACORT
Active strength
18 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220524-001DEFLAZACORTDEFLAZACORT6MGTABLET / ORALAB2026-09-18
A220524-002DEFLAZACORTDEFLAZACORT18MGTABLET / ORALAB2026-09-18
A220524-003DEFLAZACORTDEFLAZACORT30MGTABLET / ORALAB2026-09-18
A220524-004DEFLAZACORTDEFLAZACORT36MGTABLET / ORALAB2026-09-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A220524-001AB
A220524-002AB
A220524-003AB
A220524-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220524-001DEFLAZACORT6MGTABLET / ORALAB2026-09-18d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-002DEFLAZACORT18MGTABLET / ORALAB2026-09-18d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-003DEFLAZACORT30MGTABLET / ORALAB2026-09-18d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-004DEFLAZACORT36MGTABLET / ORALAB2026-09-18d4dbc9d85df4…
2026-10-15 13:18:302026-09A220524-001DEFLAZACORT6MGTABLET / ORALAB2026-09-18c2088c7a36db…
2026-10-15 13:18:302026-09A220524-002DEFLAZACORT18MGTABLET / ORALAB2026-09-18c2088c7a36db…
2026-10-15 13:18:302026-09A220524-003DEFLAZACORT30MGTABLET / ORALAB2026-09-18c2088c7a36db…
2026-10-15 13:18:302026-09A220524-004DEFLAZACORT36MGTABLET / ORALAB2026-09-18c2088c7a36db…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220524-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-003AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220524-004AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220524-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220524-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220524-003AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220524-004AB1c2088c7a36db…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Deflazacort
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DEFLAZACORT18 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
KR5YZ6AE4BInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
153098Internal RxNorm lookup
153880Internal RxNorm lookup
1870954Internal RxNorm lookup
1870958Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
00df3169-b8e3-4584-823b-91b71807d1a6Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DeflazacortDEFLAZACORTHikma Pharmaceuticals USA Inc.00df3169-b8e3-4584-823b-91b71807d1a62026-10-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220524
application number: ANDA220524
ndc (package): 0054-0825-13
ndc (product): 0054-0825
ndc11 (package): 00054082513

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0054-0825-130005408251330 TABLET in 1 BOTTLE (0054-0825-13) 30 tablet2026-10-07NoNoCurrent